Page 37 - Service Testing News Today

AstraZeneca plans to roll out variant-resistant vaccine this autumn The company is working with the University of Oxford to roll out the new vaccine Getty Images Thursday February 11, 2021 12:34 pm UK pharmaceutical giant AstraZeneca said it is on course to roll out a variant-resistant Covid-19 vaccine in the autumn this year, as clinical trials begin this spring. The FTSE 100 company announced the schedule as it unveiled its annual results,  reported on 11 February. “In collab...

Pipeline & Process Services Market Worth $4.0 Billion by 2025 - Exclusive Report by MarketsandMarkets "Pipeline & Process Services Market by Asset Type (Pipeline: T&D; Process: FPS, Refinery & Petrochemical, Gas Storage & Processing), Operation (Pre-commissioning & Commissioning, Maintenance, Decommissioning), Region - Global Forecast to 2025", published by MarketsandMarkets, the Pipeline & Process Services Market size will grow to USD 4.0 billion by 2025 (forecast year) from USD 3.1 billion i...

by Asset Type (Pipeline: T&D; Process: FPS, Refinery & Petrochemical, Gas Storage & Processing), Operation (Pre-commissioning & Commissioning, Maintenance, Decommissioning), Region - Global Forecast to 2025", published by MarketsandMarkets™, the Pipeline & Process Services Market size will grow to USD 4.0 billion by 2025 (forecast year) from USD 3.1 billion in 2020 (estimated year), at a CAGR of 5.5% during the forecast period. The rising demand for crude oil & natural gas, especially from A...

Investors have had a rough time betting on aducanumab— Biogen’s experimental treatment for Alzeheimer’s disease. The company called its clinical trials a failure, then a success. Government reviewers favored approval, then a panel of outside experts found Biogen’s studies inconclusive. The stock (ticker: BIIB) has yo-yoed between 268 and 375 in the last year, with it trading around $279 by mid-Thursday. That was up 5% from the open, and one of the things lifting it might have bee...

New data on early-stage trials of Johnson & Johnson’s Covid-19 vaccine are giving experts increased confidence that the vaccine will work as they await results of a large Phase 3 trial expected in the coming weeks. The trial data, published Wednesday by the New England Journal of Medicine, offered an expanded and updated account of a paper posted weeks ago on a so-called preprint server. The paper showed that 90% or more of participants developed neutralizing antibodies against the vi...

Moderna, it could speed up global inoculation if it proves effective. Speaking at J.P. Morgan’s health care investor conference on Monday, Johnson & Johnson CEO Alex Gorsky said that the company aimed to have “hundreds of millions of doses” of the vaccine available in the first half of this year, and “close to one billion” by the end of the year. “We’re still on track to be able to achieve those volumes,” Gorsky said. “And again, we’re working night and day to see wha...

Indonesia, the Philippines and Turkey plan to use Sinovac’s CoronaVac inoculation despite a trial in Brazil in which its effectiveness was only slightly above the WHO’s 50% threshold.

U.K. drugmaker AstraZeneca has applied for emergency-use authorization in Europe of the Covid-19 vaccine it developed with the University of Oxford, a step toward the rollout of more shots across the region.

Jan. 12, 2021 3:01 pm ET Iran and Cuba have begun trials of a joint Covid-19 vaccine, as Tehran fights the worst coronavirus outbreak in the Middle East while pledging not to use vaccines from the U.S. and U.K. The Cuban vaccine, called Soberana 02, is the most advanced of Cuba’s four vaccine candidates and will be developed in cooperation between Cuba’s Finlay Vaccine Institute and Iran’s Pasteur Institute, authorities from both countries said Monday. The cooperation between two...

An experimental Alzheimer’s drug from Eli Lilly helped patients in a small trial, the company said, renewing hopes that researchers are closing in on therapies that can fight the disease.